Skip to content
Back to the blog Blog

How Is an Artificial Intelligence Tool Clinically Validated?

Just because an AI tool works technically does not mean it is ready for use in medicine. Its validation must go beyond accuracy: it must demonstrate clinical utility, safety, reliability, and appropriate integration into the care process, while always preserving the clinician’s judgment.

Every year, hundreds of AI algorithms are published with excellent metrics in retrospective studies; very few are validated in a real clinical setting.

Beyond its technical performance, using artificial intelligence in a field as sensitive as healthcare requires considering other factors. New technologies must be ready to become part of complex clinical processes and provide sufficient assurances of safety, reliability, and control for both clinicians and patients.

That is why demonstrating that an AI tool works is not the same as demonstrating that it is ready for use in medicine.

Validating AI means more than checking that it works

There is a difference between an artificial intelligence tool that works correctly under specific conditions and a tool that has been validated for use in a particular clinical context.

Validating a clinical AI tool means clearly understanding its role: what it will measure or analyze, what data it will use, what results are expected, what those results will be compared against, and the context in which it will be used.

The healthcare sector is broad and encompasses many different functions. A tool designed to organize clinical information does not require the same safeguards as one involved in detecting potential risks. That is why defining the purpose and context of use from the outset is key to determining whether a tool truly adds value.

Before implementation, AI must comply with relevant regulatory frameworks, such as the FDA’s SaMD (Software as a Medical Device) framework or CE marking requirements, and be tested in settings that approximate, as closely as possible, the conditions in which it will be used. It is also important to understand how clinicians receive it and, when applicable, how patients interact with it.

Privacy is another essential consideration. Tools that work with health information must pay particular attention to data protection and security throughout their entire use lifecycle.

Accuracy is not the same as clinical utility

Accuracy can be one of artificial intelligence’s main advantages. However, in medicine, it is necessary to distinguish between performance metrics (sensitivity, specificity) and metrics of real clinical impact (reduced readmissions, time to diagnosis, decisions that actually change).

An AI tool can deliver good results on a specific test and still offer little value if it does not address a real clinical need or is difficult to integrate into clinicians’ workflows.

For this reason, developing artificial intelligence for medical use must also be grounded in an understanding of the clinical context: knowing the problems clinicians face, which tasks could be optimized, and how technology can help them devote more time to activities that require their judgment and expertise. In mental health, this can mean structuring the information patients generate between visits to support continuity of care over time, without replacing the clinician’s judgment in the final assessment.

Healthcare is a particularly sensitive setting because care decisions and processes can directly affect people’s lives. That is why clinicians need to know what a tool does, what its limitations are, and what happens when its results are incorrect.

The question is not only whether an AI tool works, but whether clinicians can use it safely, understandably, and appropriately within the care process.

The questions clinical AI must answer

The initial concerns artificial intelligence may raise in healthcare can relate to several fundamental questions. Regarding the population in which it has been tested, for example, there is a risk of algorithmic bias if the model was validated in a population that is not representative of the clinician’s own patient population. The relationship between the clinician and AI, focused on the tasks each performs, is another issue to resolve. As for oversight, the European Regulation requires a human-in-the-loop approach, preserving the clinician’s role.

Answering these questions makes it possible to go beyond a technical demonstration and assess whether a tool is truly ready to become part of clinical practice.

Technological solutions can be highly useful to healthcare professionals and help address some of the sector’s current challenges, but they cannot be introduced without careful consideration. They must be suited to a complex context in which errors can have significant consequences.

AI must have a validation process appropriate to its function, clear conditions of use, and efficient coordination with the clinician. The goal should not be to add yet another tool to daily work, but to provide support that makes clinical work easier without replacing the clinician’s judgment.

In medicine, working is not enough

It is necessary to know what data it was validated with, the population and context in which it was tested, what its limitations are, how errors are managed, and how it integrates into clinicians’ work.

Physicians face an increasingly complex situation in which artificial intelligence can become a highly useful support tool. But its adoption must address real needs, maintain clinical rigor, and ensure the protection of patient information.

Before introducing AI into clinical practice, the question should not only be "Does it work?" but also "Can I trust how, when, and for what purpose it is used?"

See what we are building

Explore how Bruna, Nexi Health's conversational AI, supports people's mental health.

Latest articles

Don't miss a thing.

News on AI in mental health, product updates and clinical findings, straight to your inbox.

By subscribing you accept the privacy policy.